Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (191-200 of 228) with videos related to

Pageof 23
Sort By:
Cell Cycle (Georgetown, Tex.)|January 21, 2012
The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastomaLucia Liguori, Immacolata Andolfo, Paqualino de Antonellis, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
International Journal of Cancer|July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating SurvivinKristina Althoff, Sven Lindner, Andrea Odersky, et al.
Frontiers in Immunology|April 17, 2020
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4<sup>+</sup> CAR T Cell EfficacySolin Ali, Karin Toews, Silke Schwiebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Oncogenesis|November 20, 2020
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisSilke Nothdurft, Clotilde Thumser-Henner, Frank Breitenbücher, et al.
Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.
Genes, Chromosomes & Cancer|September 8, 2007
ArrayCGH-based classification of neuroblastoma into genomic subgroupsEvi Michels, Jo Vandesompele, Katleen De Preter, et al.
Oncotarget|December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsKristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Pageof 23

Showing results (191-200 of 228) with videos related to

Sort By:
Pageof 23
Cell Cycle (Georgetown, Tex.)|January 21, 2012
The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastomaLucia Liguori, Immacolata Andolfo, Paqualino de Antonellis, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
International Journal of Cancer|July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating SurvivinKristina Althoff, Sven Lindner, Andrea Odersky, et al.
Frontiers in Immunology|April 17, 2020
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4<sup>+</sup> CAR T Cell EfficacySolin Ali, Karin Toews, Silke Schwiebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Oncogenesis|November 20, 2020
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisSilke Nothdurft, Clotilde Thumser-Henner, Frank Breitenbücher, et al.
Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.
Genes, Chromosomes & Cancer|September 8, 2007
ArrayCGH-based classification of neuroblastoma into genomic subgroupsEvi Michels, Jo Vandesompele, Katleen De Preter, et al.
Oncotarget|December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsKristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Pageof 23